551 related articles for article (PubMed ID: 23007005)
41. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
42. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
43. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
[TBL] [Abstract][Full Text] [Related]
44. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission.
Guardiola J; Lobatón T; Rodríguez-Alonso L; Ruiz-Cerulla A; Arajol C; Loayza C; Sanjuan X; Sánchez E; Rodríguez-Moranta F
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1865-70. PubMed ID: 24993368
[TBL] [Abstract][Full Text] [Related]
45. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
46. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
47. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity.
Maione F; Giglio MC; Luglio G; Rispo A; D'Armiento M; Manzo B; Cassese G; Schettino P; Gennarelli N; Siciliano S; D'Armiento FP; De Palma GD
Tech Coloproctol; 2017 Jul; 21(7):531-540. PubMed ID: 28674950
[TBL] [Abstract][Full Text] [Related]
48. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
[TBL] [Abstract][Full Text] [Related]
50. Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis.
Gundersen MD; Goll R; Fenton CG; Anderssen E; Sørbye SW; Florholmen JR; Paulssen RH
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00082. PubMed ID: 31584460
[TBL] [Abstract][Full Text] [Related]
51. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
52. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
[TBL] [Abstract][Full Text] [Related]
53. Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis.
Maeda Y; Ohtsuka K; Kudo SE; Wakamura K; Mori Y; Ogata N; Wada Y; Misawa M; Yamauchi A; Hayashi S; Kudo T; Hayashi T; Miyachi H; Yamamura F; Ishida F; Inoue H; Hamatani S
World J Gastroenterol; 2015 Feb; 21(7):2108-15. PubMed ID: 25717245
[TBL] [Abstract][Full Text] [Related]
54. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
[TBL] [Abstract][Full Text] [Related]
55. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
[TBL] [Abstract][Full Text] [Related]
56. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.
Dai C; Jiang M; Sun MJ; Cao Q
J Gastroenterol Hepatol; 2018 May; 33(5):990-997. PubMed ID: 29427297
[TBL] [Abstract][Full Text] [Related]
57. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
[TBL] [Abstract][Full Text] [Related]
58. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
59. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
[TBL] [Abstract][Full Text] [Related]
60. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients?
Kato J; Kuriyama M; Hiraoka S; Yamamoto K
J Gastroenterol Hepatol; 2011 Apr; 26(4):683-7. PubMed ID: 21054518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]